Agios Pharm (AGIO) support and resistance · rev $65.5M
Agios Pharm (AGIO) is a biotechnology company listed on US.
This page maps Agios Pharm (AGIO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported AGIO revenue for 2026-06-30 was $65.5M. Net income was -$199.8M. AGIO currently screens at market cap $1.68B.
AGIO currently screens at market cap $1.68B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new AGIO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the AGIO quote page for the session range and the stock page for the full model.
Not investment advice.